Valuation: Inventage Lab, Inc.

Market Cap	334B 252M 225M 207M 188M 353M 23.85B 359M 2.5B 984M 12.49B 945M 925M 39.58B	P/E 2024	-11.5x	P/E 2025	-110x
Enterprise Value	329B 248M 221M 204M 185M 348M 23.47B 353M 2.46B 968M 12.29B 930M 910M 38.95B	EV / Sales 2024	106x	EV / Sales 2025	356x
Free-Float	73.05%	Yield 2024 *	-	Yield 2025	-

* Estimated data More valuation ratios

Latest news: Inventage Lab, Inc.

03-16	Quratis Inc. announced that it has received KRW 10.000000167 billion in funding from Inventage Lab, Inc.	CI
03-16	Inventage Lab, Inc. announced that it has received KRW 89.99724455 billion in funding from a group of investors	CI
03-09	Inventage Lab, Inc. announced that it has received KRW 8.5 billion in funding	CI
03-06	Inventage Lab, Inc. announced that it expects to receive KRW 37.25 billion in funding from a group of investors	CI
03-06	Inventage Lab, Inc. announced that it expects to receive KRW 8.5 billion in funding	CI
03-06	Inventage Lab, Inc. announced that it expects to receive KRW 52.74724455 billion in funding from a group of investors	CI
03-06	Quratis Inc. announced that it expects to receive KRW 10.000000167 billion in funding from Inventage Lab, Inc.	CI
02-26	Inventage Lab, Inc. agreed to acquire an additional 12.79% stake in Quratis Inc. for KRW 13.5 billion.	CI
12-10	Inventage Lab Seeks Approval for Phase 2 Trial of Alopecia Drug in Australia	MT
22/09/25	Inventage Lab, Inc.(KOSDAQ:A389470) added to S&P Global BMI Index	CI
12/03/25	Inventage Lab, Inc. announced that it has received KRW 9.9999925 billion in funding from PEACE to S KOREA Co., Ltd	CI
12/03/25	Quratis Inc. announced that it has received KRW 10.0329 billion in funding from Inventage Lab, Inc.	CI
21/02/25	Quratis Inc. announced that it has received KRW 15 billion in funding from Inventage Lab, Inc.	CI

More news

Managers and Directors: Inventage Lab, Inc.

Manager	Title	Age	Since
Ju-Hee Kim CEO	Chief Executive Officer	52	14/05/2015
Byeong-Yul Jeong DFI	Director of Finance/CFO	55	-
Chan-Hee Jeon CTO	Chief Tech/Sci/R&D Officer	57	-

Director	Title	Age	Since
Ju-Hee Kim BRD	Director/Board Member	52	14/05/2015
Choong-Ho Ryu BRD	Director/Board Member	56	-
Chan-Hee Jeon BRD	Director/Board Member	57	-

More insiders

Inventage Lab Inc is a Korea-based company principally engaged in the pharmaceutical business. The Company owns the platforms applied to the development and mass production of long-acting injections and drug delivery of genetic materials. The Company is engaged in the research, manufacture and sale of human medicines used for male pattern baldness, dementia, prostate cancer and others. It is also engaged in the research, manufacture and sale of veterinary medicines such as combination drugs, chemical castration agents and others.

Employees

Sector

Pharmaceuticals

More about the company

Quotes

Date	Price	Change	Volume
22/10/26	₩25,100.00	-4.20%	81,740
21/10/26	₩26,200.00	+4.38%	100,067
20/10/26	₩25,100.00	-0.20%	55,813
19/10/26	₩25,150.00	+1.62%	50,838
16/10/26	₩24,750.00	+2.48%	150,594

End-of-day quote Korea S.E.

More quotes

Select your edition

All financial news and data tailored to specific country editions

NORTH AMERICA

United-States

Canada

End-of-day quote Korea S.E. 22/10/2026			5-day change	1st Jan Change
25,100.00 ^KRW	-4.20%		-5.99%	-70.19%

1 day	-4.20%
1 week	-5.99%
Current month	-2.71%
1 month	-2.14%
3 months	-18.77%
6 months	-58.92%
Current year	-70.19%

1 week	23,500	27,500
1 month	22,550	34,000
Current year	22,550	101,700
1 year	22,550	101,700
3 years	9,400	101,700
5 years	8,440	101,700
10 years	8,440	101,700

Date	Insider	Type	Quantity	% Market Cap.
8/8/25 A	Dong Seok Park	Exercice	8,000	0.0796%
8/8/25 A	Se Yeon Kim	Exercice	10,000	0.0996%
8/8/25 A	Dong Seok Park	Exercice	8,000	0.0796%

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
INVENTAGE LAB, INC.	-4.20%	-5.99%	-33.42%	+51.94%	263M
ELI LILLY AND COMPANY	+2.82%	+4.92%	+61.64%	+127.73%	1,133B
JOHNSON & JOHNSON	+3.65%	+5.67%	+38.71%	+76.78%	621B
ABBVIE INC.	-0.51%	+0.24%	+24.23%	+96.29%	503B
ROCHE HOLDING AG	+0.03%	+3.27%	+39.79%	+65.06%	379B
MERCK & CO., INC.	-3.39%	+0.98%	+67.35%	+41.86%	370B
NOVARTIS AG	+1.58%	+2.37%	+22.91%	+52.52%	292B
ASTRAZENECA PLC	+2.90%	+2.22%	+3.51%	+28.51%	262B
AMGEN INC.	+1.90%	+3.44%	+51.69%	+64.42%	237B
GILEAD SCIENCES, INC.	+0.95%	-0.92%	+28.37%	+101.03%	190B
Average	+0.51%	+3.04%	+30.48%	+70.61%	398.82B
Weighted average by Cap.	+1.39%	+3.73%	+42.95%	+84.83%

Inventage Lab, Inc. Stock

Stocks

A389470

KR7389470006

Pharmaceuticals

Valuation: Inventage Lab, Inc.

Chart: Inventage Lab, Inc.

Latest news: Inventage Lab, Inc.

Quotes and Performance

Price Extremes

Managers and Directors: Inventage Lab, Inc.

Latest insider transactions

Other Pharmaceuticals

Financials

Company Profile

Quotes

	2024	2025
Net sales	1.78B 1.34M 1.2M 1.11M 1.01M 1.89M 127M 1.91M 13.33M 5.25M 66.68M 5.04M 4.94M 211M	2.94B 2.21M 1.98M 1.82M 1.66M 3.11M 210M 3.16M 21.97M 8.66M 110M 8.31M 8.14M 348M
Net income	-17B -12.81M -11.43M -10.55M -9.58M -17.98M -1.21B -18.25M -127M -50.06M -636M -48.08M -47.05M -2.01B	-8.46B -6.37M -5.69M -5.25M -4.77M -8.95M -604M -9.08M -63.24M -24.91M -316M -23.93M -23.42M -1B
Net Debt	-23.96B -18.06M -16.12M -14.87M -13.51M -25.35M -1.71B -25.74M -179M -70.58M -896M -67.79M -66.34M -2.84B	-5.33B -4.01M -3.58M -3.31M -3M -5.63M -380M -5.72M -39.83M -15.69M -199M -15.07M -14.75M -631M